Morning Market Movers

By: via Benzinga
Cancer Genetics (NASDAQ: CGIX) shares climbed 28.33% to $7.70 on Q3 results. The company reported a Q3 loss of $0.41 per share on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.